VO

Vincent Ossipow

Chief Scientific Officer (CSO) at Omega Alpha SPAC (Nasdaq OMEG)

Geneva, Geneva

Overview 

Vincent Ossipow is a Partner at Omega Funds in Geneva, specializing in venture capital and private equity investments in sectors such as Digital Health and BioTech. With a background as a CFA Charterholder and experience serving on multiple boards of directors, he has successfully invested in companies like Aerium Therapeutics and Andrew Alliance, demonstrating his expertise in portfolio management and equity research.

Work Experience 

  • Partner

    2014 - Current

  • Partner at Omega Funds

    2014

  • Partner

    2014 - 2017

Omega Funds global life sciences-based investment firm that specializes in direct secondary transactions.

  • Chief Scientific Officer (CSO)

    2021

  • Member of the Board of Directors

    2007

    Current Board Seats: -Callio Therapeutics (USA, private) -Bioinvent (Sweden, publicly listed), Board Director, prior member of the Audit Committee -Sophia Genetics (Switzerland, NASDAQ listed), Independent Board Director, member of the Remuneration Committee -FoRx (Switzerland, private), Board Director, member of the Nomination Committee -Anaconda Brain (Spain, private), Board observer Prior Board of Director experience: -Etherna Immuno-Oncology (Belgium, private), Chairman of the Audit Committee, Board Director -Andrew Alliance (Switzerland, private), Board Director, member of the Remuneration Committee. Acquired -LifeSpan (USA, private), Board Director. Acquired -Raindance Technologies (USA, private), Board Director. Acquired -Kuros Biosciences (Switzerland, publicly traded), Board Director, Chairman of the Audit Committee -Endosense (Switzerland, private), Board observer. Acquired -Aerium Therapeutics (USA-Switzerland, private), Board Director. Liquidated -Immunic (USA, NASDAQ listed), Board Director, Chairman of the Nomination Committee, prior member of the Audit Committee, prior member of the Remuneration Committee

  • Partner Private Equity

    2012 - 2013

  • Investment Manager

    2007 - 2012

  • Faculty Member

    2000 - 2007

  • Financial Analyst

    1998 - 2000

  • Postdoctoral Fellow

    1997 - 1998

Technology Transfer Center (TTC) facilitates partnerships between the NIH research laboratories and external partners.

Articles About Vincent

Relevant Websites